GlobeNewswire by notified

Delårsrapport Q3 2022 Elon AB

Share

Tredje kvartalet 2022
• Nettoomsättningen i kvartalet ökade med 31,0 procent till 1 427,4 MSEK (1 089,4) varav samgåendet med Electra påverkade positivt med 403 MSEK.
• Organisk omsättningstillväxt för kvartalet var negativ med -6,0 procent (8,7).
• Bruttomarginalen uppgick till 12,2 procent (13,2).
• Rörelseresultatet (EBIT) uppgick till 18,7 MSEK (28,6) motsvarande en rörelsemarginal om 1,3 procent (2,6).
• Resultat före skatt uppgick till 13,8 MSEK (27,8).
• Kassaflödet från den löpande verksamheten justerat för effekter av samgåendet uppgick för kvartalet till 64,7 MSEK (42,7).
• Resultat per aktie före utspädning uppgick till 0,94 SEK (4,24) och efter utspädning till 0,90 SEK (4,24).

Viktiga händelser under kvartalet
Avyttring av affärssystemet Smart genomfördes under kvartalet med en positiv resultateffekt redovisad under övriga rörelseintäkter med 9,5 MSEK.

Januari 2022 – September 2022
• Nettoomsättningen ökade i perioden med 18,8 procent till 3 622,3 MSEK (3 047,9), varav samgåendet med Electra påverkat positivt med 631 MSEK i perioden.
• Den organiska omsättningstillväxten var -1,9 procent (13,9).
• Bruttomarginalen uppgick till 13,9 procent (13,3).
• Transaktionskostnader av engångskaraktär kopplade till samgåendet mellan Elon och Electra belastade rörelseresultatet i perioden med 18,9 MSEK.
• Rörelseresultatet (EBIT) uppgick till 14,5 MSEK (47,2) motsvarande en rörelsemarginal om 0,4 procent (1,5).
• Justerad EBIT uppgick till 33,4 MSEK (47,2) motsvarande en justerad EBIT-marginal om 0,9 procent (1,5).
• Resultat före skatt uppgick till 2,0 MSEK (44,3).
• Kassaflödet från den löpande verksamheten uppgick till -55,7 MSEK (-119,9).
• Resultat per aktie före utspädning uppgick till 0,17 SEK (6,76) och efter utspädning till 0,17 SEK (6,76).

Viktiga händelser under perioden
Per den 16 maj genomfördes en apportemission i Elon AB genom riktad nyemission till Elon Group Holding AB på totalt 9 659 223 aktier. Som betalning för aktierna erhölls 100 procent av aktierna i bolaget Elon Group AB. Samgåendet mellan Elon AB och Elon Group AB redovisas som ett omvänt förvärv vilket innebär att Elon AB är det legala moderbolaget men behandlas redovisningsmässigt som det förvärvade bolaget. Elon Group AB är det legala dotterbolaget men behandlas redovisningsmässigt som det förvärvande bolaget.

För mer information vänligen kontakta:
Stefan Lebrot, CEO stefan.lebrot@elongroup.se
Peter Brodén, CFO peter.broden@elongroup.se

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Major shareholder notification – Norges Bank3.12.2022 14:45:28 CET | Press release

GN Store Nord A/S hereby announces that on December 2, 2022, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from Norges Bank stating that on December 1, 2022 Norges Bank decreased its aggregate holding of shares and financial instruments, cf. Section 38(1) and Section 39(2)(1) of the Danish Capital Markets Act, to under 5% of the share capital and voting rights in GN Store Nord A/S. For further information, please contact: Investors and analysts Anne Sofie Staunsbæk Veyhe Vice President – Investor Relations, Treasury & M&A Tel: +45 45 75 85 06 or Rune Sandager Senior Director – Investor Relations Tel: +45 45 75 92 57 Press and the media Steen Frentz Laursen Vice President, Corporate Communications Tel: +45 20 65 34 20 About GN GN facilitates communication between people through intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our passion for innovation, we leverage technologies to deliv

Brookfield Announces Reset Dividend Rate on Its Series 30 and Series 48 Preference Shares3.12.2022 03:45:00 CET | Press release

All amounts in Canadian dollars unless otherwise stated. BROOKFIELD, NEWS, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Brookfield (NYSE: BAM, TSX: BAM.A) today announced that it has determined the fixed dividend rate on its Cumulative Class A Preference Shares, Series 30 (“Series 30 Shares”) (TSX: BAM.PR.Z) for the five years commencing January 1, 2023 and ending December 31, 2027, and also determined the fixed dividend on its Cumulative Class A Preference Shares, Series 48 (“Series 48 Shares”) (TSX: BAM.PF.J) for the five years commencing January 1, 2023 and ending December 31, 2027. As previously disclosed, the Series 30 Shares and Series 48 Shares are expected to commence trading on the TSX under the updated symbols “BN.PR.Z” and “BN.PF.J”, respectively, on December 12, 2022. Series 30 Shares and Series 31 Shares If declared, the fixed quarterly dividends on the Series 30 Shares during the five years commencing January 1, 2023 will be paid at an annual rate of 6.089% ($0.3805625 per share per

EverWind selects Black & Veatch for Front-end Engineering Design of First Green Hydrogen Hub in Nova Scotia2.12.2022 20:23:30 CET | Press release

HALIFAX, Nova Scotia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- EverWind Fuels Company ("EverWind") today announces it has selected Black & Veatch to provide front-end engineering design (FEED) services for its green hydrogen and ammonia production and storage facility in Point Tupper, Nova Scotia, with initial commercial operations planned for 2025. EverWind is a private developer of green hydrogen and ammonia production and storage sites, and global engineering and construction company Black & Veatch is a green energy solutions leader. In its first phase, the facility will produce green hydrogen and green ammonia through electrolysis using certified green power from the Nova Scotia Power transmission system; onshore wind generation will power production in a second phase. In future phases, EverWind will use offshore wind power to produce hydrogen through electrolysis, unlocking Nova Scotia’s offshore wind capabilities. The first two phases will produce a combined 1 million tonnes per annum o

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA2.12.2022 19:00:00 CET | Press release

Negma Group has converted 322convertible bonds in Oxurion resulting in a EUR 805,000capital increase. This is part of Negma Group’s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion. Leuven, BELGIUM,Boston, MA, US–December2, 2022– 07.00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Oxurion NV (Euronext Brussels: OXUR) (the “Company” or “Oxurion”), announces the below information, following (i) the issuance of 63,550,419 new ordinary shares on November 28, 2022, for a total amount of EUR 605,000, as the result of the conversion of 242 class B convertible bonds, and (ii) the issuance of 21,008,403 new ordinary shares on November 30, 2022, for a total amount

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons2.12.2022 18:05:00 CET | Press release

Company announcement – No. 56/ 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark and Boston, MA, U.S. December 2, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have re